K172311

Substantially Equivalent

BioFlux Device

Applicant: Biotricity, Inc.
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2017-08-01
Decision date: 2017-12-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Redwood City, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.